2025-04-08 18:21:19
Latest Post
Godrej Properties delivers its highest ever quarterly and full year bookings
Poonawalla Fincorp Launches Shopkeeper Loan Business
Revolt Motors Expands to 200 Dealerships, Targets 400 by FY26
Sobha Ltd - Real Estate Operational Update - Q4 FY 2024-25
Lemon Tree Hotels signs a new property in DarjeelingStock Report
Lincoln Pharmaceuticals Ltd posts rise in Q2FY23 consolidated profit to Rs. 23.71 crores
Posted On : 2022-11-11 11:15:11( TIMEZONE : IST )
Lincoln Pharmaceuticals Limited has reported Consolidated financial results for the period ended September 30, 2022.
Financial Results (Q2 FY2023) - QoQ Comparison
The company has reported total income of Rs. 146.3335 crores during the period ended September 30, 2022 as compared to Rs. 129.9656 crores during the period ended June 30, 2022.
The company has posted net profit / (loss) of Rs. 23.7129 crores for the period ended September 30, 2022 as against net profit / (loss) of Rs. 15.0116 crores for the period ended June 30, 2022.
The company has reported EPS of Rs. 11.84 for the period ended September 30, 2022 as compared to Rs. 7.49 for the period ended June 30, 2022.
| Financials | Q2 FY2023 | Q1 FY2023 | % Change |
| Total Income | ₹ 146.3335 crs | ₹129.9656 crs |  12.59% |
| Net Profit | ₹23.7129 crs | ₹15.0116 crs | 57.96% |
| EPS | ₹11.84 | ₹7.49 | 58.08% |
Financial Results (Q2 FY2023) - YoY Comparison
The company has reported total income of Rs. 146.3335 crores during the period ended September 30, 2022 as compared to Rs.130.9281 crores during the period ended September 30, 2021.
The company has posted net profit / (loss) of Rs.23.7129 crores for the period ended September 30, 2022 as against net profit / (loss) of Rs.23.0267 crores for the period ended September 30, 2021.
The company has reported EPS of Rs.11.84 for the period ended September 30, 2022 as compared to Rs.11.50 for the period ended September 30, 2021.
| Financials | Q2 FY2023 | Q2 FY2022 | % Change |
| Total Income | ₹ 146.3335 crs | ₹130.9281 crs | 11.77% |
| Net Profit | ₹23.7129 crs | ₹23.0267 crs | 2.98% |
| EPS | ₹11.84 | ₹11.50 | 2.96% |
Financial Results (Half Year Ended FY2023) - YoY Comparison
The company has reported total income of Rs.276.2991 crores during the 6 Months period ended September 30, 2022 as compared to Rs.255.1276 crores during the 6 Months period ended September 30, 2021.
The company has posted net profit / (loss) of Rs.38.7245 crores for the 6 Months period ended September 30, 2022 as against net profit / (loss) of Rs.40.7292 crores for the 6 Months period ended September 30, 2021.
The company has reported EPS of Rs.19.33 for the 6 Months period ended September 30, 2022 as compared to Rs.20.33 for the 6 Months period ended September 30, 2021.
| Financials | Half Year Ended FY2023 | Half Year Ended FY2022 | % Change |
| Total Income | ₹276.2991 crs | ₹255.1276 crs | 8.30% |
| Net Profit | ₹38.7245 crs | ₹40.7292 crs |  -4.92% |
| EPS | ₹19.33 | ₹20.33 | -4.92% |
Shares of Lincoln Pharmaceuticals Limited was last trading in BSE at Rs. 305.85 as compared to the previous close of Rs. 301.35. The total number of shares traded during the day was 11240 in over 1003 trades.
The stock hit an intraday high of Rs. 311.00 and intraday low of 297.80. The net turnover during the day was Rs. 3421405.00.
